Date Item Type Full Text Status

Public

A comparison of reimbursement recommendations by European HTA agencies : Is there opportunity for further alignment? (2017) Nicola Allen, Lawrence Liberti, Stuart R. Walker and Sam Salek

Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment : A Systematic Review of the Literature. (2017) M Bujar, N McAuslane, S Walker and Mir-Saeed Shayegan Salek

Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review. (2023) Stefanie Ho Yi Chan, Yasmin Khatib, Sherael Webley, Deborah Layton and Sam Salek

The Development and Validation of a Generic Instrument, QoDoS, for Assessing the Quality of Decision Making. (2016) R Donelan, Stuart Walker and Mir-Saeed Shayegan Salek

The South African Regulatory System: Past, Present, and Future. (2018) A Keyter, Shabir Banoo, Mir-Saeed Shayegan Salek and Stuart R. Walker

The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland. (2019) Andrea Keyter, Mir-Saeed Shayegan Salek, Shabir Banoo and Stuart R. Walker

South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access. (2021) Andrea Keyter, Sam Salek, Lorraine Danks, Portia Nkambule, Boitumelo Semete-Makokotlela and Stuart Walker

Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer. (2018) Uchini S Kosgodage, Rhys Mould, Aine Henley, alistair Nunn, Geoffrey Guy, E. Louise Thomas, Jameel Inal, Jimmy Bell and Sigrun Lange

A practical approach to communicating benefit-risk decisions of medicines to stakeholders. (2015) J Leong, S Walker and Mir-Saeed Shayegan Salek

Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain. (2022) Lisa A. Lione and Amy Fisher

Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain, volume II. (2024) Lisa A. Lione and Amy Fisher

Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward. (2022) Nancy Ngum, Jane Mashingia, Margareth Ndomondo-Sigonda, Stuart Walker and Sam Salek

Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement. (2022) Nancy Ngum, Jane Mashingia, Margareth Ndomondo-Sigonda, Stuart Walker and Sam Salek

Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries. (2022) Mercy Owusu-Asante, Delese Mimi Darko, Stuart Walker and Sam Salek

Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry. (2023) Mercy Owusu-Asante, Delese Mimi Darko, Stuart Walker and Sam Salek

Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines. (2018) Hasumati Rahalkar, Hacer Coskun Cetintas and Mir-Saeed Shayegan Salek

Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices. (2021) Hasumati Rahalkar, Alan Sheppard and Sam Salek

Factors influencing delays in patient access to new medicines in Canada: a retrospective study of reimbursement processes in public drug plans. (2019) Mir-Saeed Shayegan Salek, Sarah Lussier Hoskyn, Jeffrey Johns, Nicola Allen and Chander Sehgal

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications. (2019) Mir-Saeed Shayegan Salek, Sarah Lussier Hoskyn, Jeffrey Johns, Nicola Allen and Chander Sehgal

Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy. (2023) Cijo George Vazhappilly, Shoib Sarwar Siddiqui, Ruby John Anto, Rajan Radhakrishnan and Naveen Kumar Devanga Ragupathi

Restricted

Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service. (2018) Dalia M Dawoud, David Wonderling, Jessica Glen, Sedina Lewis, Xavier Griffin, Beverley J Hunt, Gerard Stansby, Michael Reed, Nigel Rossiter, Jagjot Chahal, Carlos Sharpin and Peter Barry

Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research : Translatable and Bidirectional Research. (2021) Amy Fisher, Michael Lanigan, Neil Upton and Lisa Lione

Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO) : Content Validity. (2020) Pushpendra Goswami, Esther Oliva, Tatyana Ionova, R Else, J Kell, AK Fielding, DM Jennings, M Karakantza, S Al-Ismail, GP Collins, S McConnell, Catherine Langton and Sam Salek

Is there a potential of misuse for venlafaxine and bupropion? (2018) Fabrizio Schifano and Stephania Chiappini

Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems. (2019) Fabrizio Schifano, Stephania Chiappini, John Corkery and Amira Guirguis